The anonymized data supporting the study is available within the paper and its Supporting Information files.

Introduction {#sec004}
============

Access to free services remains a significant challenge to receiving quality healthcare in resource-limited settings and is a cause of underutilization of healthcare by men \[[@pone.0224749.ref001]\]. While male involvement in healthcare as partners or fathers has been extensively studied in the developing world context \[[@pone.0224749.ref002]--[@pone.0224749.ref006]\], far less emphasis has been placed on the health-seeking behavior of men as clients themselves. Often, studies analyzing men's attendance at rural health clinics in low-income settings have focused on their involvement in programs related to maternal and child health, especially programs to decrease mother-to-child transmission of HIV \[[@pone.0224749.ref005], [@pone.0224749.ref007]--[@pone.0224749.ref010]\]. However, far fewer programs and research initiatives in low-income countries focus on men exclusively as independent agents seeking access to healthcare \[[@pone.0224749.ref011]\]. This is problematic because seeking care is often seen as counter-normative for men, particularly in patriarchal societies, and is instead an activity viewed as particularly necessary for women and children \[[@pone.0224749.ref012]--[@pone.0224749.ref014]\]. Furthermore, clinics are often viewed as "female spaces," because females usually make up most of the patient and caregiver population in these settings \[[@pone.0224749.ref012]\]. As a result, it is common for men to only seek care during emergencies or in the later stages of preventable illnesses \[[@pone.0224749.ref015]--[@pone.0224749.ref017]\].

The "male clinics" intervention aimed to narrow this gap in male health-seeking behavior in western Kenya, where services are primarily accessed by women and children. Since services are also mostly provided by female health workers, the research hypothesis of the qualitative study was that men's concerns over confidentiality and views about gender norms are barriers to their uptake of services at clinics. Preliminary research was conducted to learn the reasons local men were not more frequently visiting clinics, and subsequently a "male clinics" (MCs) intervention was implemented to address the identified challenges. In viewing men as patients in their own right and providing a space to meet their individual needs confidentially and sensitively, we sought to create a more enabling clinical environment with the goal of ultimately increasing men's uptake of health services. The paper highlights the benefit of a general health approach, rather than a disease-based approach, to engage men in health services.

By appointing male health workers and directing services to men alone in a separate area within a clinic, we aimed to create an incentive for men to seek care. The hypothesis was that a male-friendly space would improve men's health-seeking behavior and increase uptake of care by reducing cultural barriers, particularly in the case of stigmatized or sensitive conditions. Also, targeted services were intended to improve efficiency as an added incentive, since patients are often required to wait a long time for care at clinics in resource-limited settings.

Materials and methods {#sec005}
=====================

Study area {#sec006}
----------

The study site was located in Sauri, Siaya county in western Kenya within a Millennium Villages Project (MVP) site. The MVP context has been described previously \[[@pone.0224749.ref018]--[@pone.0224749.ref019]\]. Sauri contains 11 villages and the total catchment population for the health facilities is 73,089. Adult men over 18 years of age make up approximately 13·3% (n = 9,713) of the total population \[[@pone.0224749.ref020]\]. There are 10 health facilities, one of which offers free care for all services to men. In other clinics, care is only completely free for pregnant women and children under five; some basic care is free for all. Only Ramula and Nyawara intervention clinics offered free voluntary medical male circumcision, while the others did not. Both clinics were low volume sites.

Preliminary focus groups and trial {#sec007}
----------------------------------

In the first phase of this study (October-December 2013), a qualitative questionnaire was fielded with 124 men over 18 years old in Sauri district to assess utilization and perceptions of local clinics. MVP staff led recruitment. Community Health Workers (CHWs) spread awareness of the questionnaire during home visits and others recruited by word-of-mouth during community events such as "men's health days." A convenience sample was established by selecting men from communities with differing proximities to clinics.

Kenyan data clerks who worked for MVP were trained in survey administration. The questionnaire was available in English, Swahili and Luo. The interviewers conducted structured focus group discussions and individual interviews, including questions about frequency of and reasons for past clinic visits, along with open-ended questions about reasons men would visit a clinic, obstacles preventing men from accessing care and possible improvements to the health centers.

Following the focus groups, MVP conducted a one-month pilot MC at two clinics in Sauri. As part of this pilot, we organized a "men's health day," which was a sensitization day involving a male nurse at each clinic providing education to male visitors primarily about sexual health, as per focus group recommendations. Men were then seen by a male clinical officer hired by MVP for individual consultation at a unit separate from the clinic that caters to women and children; services were free.

Establishment of male clinics {#sec008}
-----------------------------

Following feedback from the one-month pilot, we designed an MC intervention, hiring two dedicated male health workers to be stationed in a designated area within existing healthcare facilities to offer free services exclusively to male patients on a specific day of every month. We carried out this intervention for 12 months at five local health facilities to determine the impact of a male-friendly clinic on male attendance rates at the health centers, and its impact on specific health-seeking behaviors associated with free simplified access.

Intervention activities {#sec009}
-----------------------

The two male health workers were stationed for several daytime hours once per month at five clinics---Lihanda, Marenyo, Nyawara, Ramula, and Sauri---in an isolated area within each clinic to ensure privacy. During consultations, the health workers filled out a register with basic information about the visit, but no identifiable information was recorded to comply with ethical review board requirements ([S1 Appendix](#pone.0224749.s001){ref-type="supplementary-material"}).

The health workers at the MC offered a range of services for common ailments ([Table 1](#pone.0224749.t001){ref-type="table"}). Preventive care was also available, including HIV testing, STI screening, and blood pressure checks, and men were referred if necessary.

10.1371/journal.pone.0224749.t001

###### Common ailments that Male Clinics were equipped to treat.

![](pone.0224749.t001){#pone.0224749.t001g}

  ----------------------------------
  Malaria
  URTI
  STI
  Enteric fever
  Neuritis
  Gastroenteritis
  Fungal infections
  Hypertension
  Diabetes
  Epilepsy
  Arthritis
  Allergy
  Injury/trauma
  Sexual dysfunction
  UTI
  Peptic ulcer disease
  Pneumonia, asthma, pleurisy/LRTI
  Dental problems (referral)
  Myalgia
  Cellulitis
  Other
  ----------------------------------

Evaluation design {#sec010}
-----------------

Patient registers were collected from clinics in four groups: 1) "Intervention," which was data collected on MC days, 2) "Concurrent control at intervention clinics," which was data from the same clinics where the intervention took place during the same time period, but on days when the MC did not occur, 3) "Concurrent control at different clinics," was data from five clinics which did not have MCs during the same time period as the intervention, and 4) "Historic control," which was data from intervention clinics two years prior from November 2012 to November 2013.

MCs were open during the same hours as control clinics.

Because no identifiable information was collected, the unit of analysis was visits, not people, with the exception of the age variable. Median age was calculated by excluding the subsequent visits of those who had visited MCs more than once to avoid double counting.

Outcomes of interest and measurement {#sec011}
------------------------------------

Outcomes of interest were divided into five groups: reason for visit, service utilization, type of diagnosis, quality of care, and the "male-friendliness" of the MCs. We aimed to understand how many visits were made by sick patients compared to healthy patients coming for check-ups, whether uptake of services increased when an MC was offered, for which ailments men sought care, whether MC clinicians appropriately diagnosed patients, and whether patients were visiting MCs for sensitive reproductive health issues.

The reason for visit was recorded as either "check-up" or "sick," as per MC clinician assessment, and was compared to the control groups. The MC clinician also recorded whether each visit was a first or follow up visit.

To measure service utilization, we calculated the number of visits on a monthly basis as a proportion of the total male population in the catchment area and compared the number of visits at MCs with the number of visits in all control groups. We also calculated the proportion of total visits that occurred monthly.

Quality of care was measured by assessing how frequently the MC clinician provided proper treatment for six common diagnoses that corresponded with standardized treatments ([Table 2](#pone.0224749.t002){ref-type="table"}). We chose these ailments because they had a finite number of treatment options in this particular setting.

10.1371/journal.pone.0224749.t002

###### Common diagnoses at Male Clinics and corresponding standardized treatments.
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  Diagnosis                    Treatment
  ---------------------------- -------------------------------------------------------
  Diabetes                     Metformin
  Hypertension                 Hydrochlorothiazide
  Epilepsy                     Anti-epileptics[^a^](#t002fn001){ref-type="table-fn"}
  Fungal infection             Anti-fungals[^b^](#t002fn002){ref-type="table-fn"}
  Peptic Ulcer Disease (PUD)   Omeprazole
  Malaria                      Artemether/Lumefantrine

^a^ Includes phenobarbital, diazepam, tegretol

^b^ Includes clozole, griseofulvin, gentian violet

Also, the dates of study collection among the concurrent control at different clinics group was limited to July-November 2015, while data was collected from November 2012-November 2013 in the historic control group and November 2014-November 2015 in the remaining two groups.

Statistical analysis {#sec012}
--------------------

Statistical analyses were conducted using SAS 9·4, STATA 14·1, SPSS 22·0, and MS Excel 2016 software. The preliminary questionnaire was analyzed using SPSS after combining open-ended responses into similar categories. To test for a difference in the number of visits made as a proportion of the total male population in the catchment area by group as a measure of service utilization, a two-sample t-test was conducted for each intervention-control group comparison and an ANOVA test was used to compare across groups. Bonferonni adjustments were made to account for multiple comparisons (alpha/3). To assess correct treatment for diagnosis by group as a measure of quality of care, a chi-square analysis was conducted comparing the proportion of diagnoses that were correctly treated by intervention or control group. Quality of care was measured by calculating the proportion of correct treatments for each diagnosis in the intervention group and was assessed using chi-square tests with a Bonferonni adjustment to account for multiple comparisons. A chi-square test was also used to assess the proportion of visits that were check-ups, and the proportion of times a provider-initiated testing and counseling (PITC) was conducted among patients who did or did not know their HIV status.

Finally, we investigated how many men were diagnosed with STIs and/or sexual dysfunction at MCs compared to the control groups, with the expectation that men were more likely to want to address these sensitive issues in an MC environment versus a regular clinic. A chi-squared test was used to compare the proportion of diagnoses that were STIs and sexual dysfunction between the intervention group and all control groups.

Results {#sec013}
=======

Preliminary questionnaire findings {#sec014}
----------------------------------

Cost of services, distance, and cost of travel were the most commonly reported barriers to visiting clinics among men who had never visited a facility (n = 112). Also, only 52·9% (n = 63) of men overall reported satisfaction with healthcare providers. Common suggestions for improvements to providers included being more respectful (32·7%, n = 33) and reducing wait times (23·8%, n = 24). Participants' most common fears about visiting facilities included a lack of confidentiality (35%, n = 7), time delays and inefficiency (20%, n = 4), and concerns about HIV testing (10%, n = 2) ([Table 3](#pone.0224749.t003){ref-type="table"}). Additionally, 86·3% (n = 107) of respondents felt that women were most likely to use health facilities; just 2·4% (n = 3) said adult men were most likely to do the same. This feedback informed the design of MCs.

10.1371/journal.pone.0224749.t003

###### Select preliminary questionnaire findings.
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                                                                                                Total number of responses   \%
  --------------------------------------------------------------------------------------------- --------------------------- -------
  **Satisfaction with health providers**                                                        119                         
  Satisfied with providers' competency                                                          65                          54.6%
  Satisfied overall                                                                             63                          52.9%
  Satisfied with provider's attitudes                                                           55                          46.2%
  **Believe improvements could be made to providers**                                           116                         93.5%
  Yes                                                                                           104                         89.7%
  No                                                                                            12                          10.3%
  **Suggestions for improvement to providers**                                                  135                         
  More respectful                                                                               40                          29.6%
  More timely                                                                                   30                          22.2%
  More staff                                                                                    25                          18.5%
  Staff provide medication                                                                      15                          11.1%
  Better trained                                                                                13                          9.6%
  Staff provide better urgent care                                                              4                           3.0%
  Ward for men                                                                                  2                           1.5%
  Staff provide free care                                                                       2                           1.5%
  Improved hygiene                                                                              1                           0.7%
  More male providers                                                                           1                           0.7%
  Less corrupt                                                                                  1                           0.7%
  Mortuary                                                                                      1                           0.7%
  **Common reasons men visit health facilities**                                                121                         
  Treatment during illness (usually severe)                                                     80                          66.1%
  HIV services                                                                                  26                          21.5%
  Malaria                                                                                       6                           5.0%
  Health information/general check-ups                                                          3                           2.5%
  Circumcision                                                                                  3                           2.5%
  Accompanying others                                                                           2                           1.7%
  First aid                                                                                     2                           1.7%
  STI services                                                                                  1                           0.8%
  Overall health                                                                                1                           0.8%
  Obstetrics                                                                                    0                           0.0%
  Family planning                                                                               0                           0.0%
  **Common fears about seeking care among men with fears**                                      25                          
  Not confidential                                                                              7                           28.0%
  Delays / inefficiency                                                                         4                           16.0%
  Scared of HIV test/result                                                                     2                           8.0%
  Fear of blood draws / injections / taking medication                                          2                           8.0%
  Service will be inaccurate / incorrect                                                        2                           8.0%
  Harshness of how staff treat patients                                                         1                           4.0%
  Expense                                                                                       2                           8.0%
  **Largest barrier to visiting health facility among men who have never visited a facility**   112                         
  Cost of services                                                                              74                          66.1%
  Distance                                                                                      15                          13.4%
  No time                                                                                       12                          10.7%
  Cost of transport                                                                             4                           3.6%
  No barriers                                                                                   3                           2.7%
  Not helpful                                                                                   1                           0.9%
  Fear of HIV test                                                                              1                           0.9%
  Attitude of health staff                                                                      1                           0.9%
  Majority of staff women                                                                       1                           0.9%

Male clinics findings {#sec015}
=====================

Demographics {#sec016}
------------

The median age of MC patients was 32. Men who visited the MC multiple times were included in this calculation only for their first visit; ages of patients coming for subsequent visits were excluded. The ages ranged from 15 to 80-years-old. Many men were farmers as agriculture is the main economic activity in the region. Most likely the younger patients were often students at a nearby university.

Number of visits {#sec017}
----------------

Comparison by ANOVA revealed that the number of visits to MCs as a proportion of the total catchment population was higher in the intervention group than the number of visits to a clinic (by population) made by men in any control group (p \< .0001).

The mean visits (and standard deviation) for each group were 3·77 (1·70) for the concurrent control at different clinics group, 21·26 (15·89) for the historic control group, 26·37 (19·32) for the intervention group, and 20·15 (15·35) for the concurrent control at intervention clinics group ([Fig 1](#pone.0224749.g001){ref-type="fig"}). Additionally, out of 571 MC visits, half (50·1%, n = 286) were re-visits ([Table 4](#pone.0224749.t004){ref-type="table"}).

![Monthly visits to clinics as a proportion of total male population in catchment area by intervention group (ANOVA).](pone.0224749.g001){#pone.0224749.g001}

10.1371/journal.pone.0224749.t004

###### Proportion of repeat visits to Male Clinics.
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  Clinic      Total visits to intervention clinics   Amount of re-visits to Male Clinics   Re-visits to Male Clinics as a proportion of total visits
  ----------- -------------------------------------- ------------------------------------- -----------------------------------------------------------
  Lihanda     182                                    95                                    52.2%
  Marenyo     107                                    52                                    48.6%
  Nyawara     67                                     20                                    29.9%
  Ramula      83                                     33                                    39.8%
  Bar Sauri   132                                    86                                    65.2%
  Total       571                                    286                                   50.1%

Reasons for visits {#sec018}
------------------

The reason for visit was recorded as either "checkup" or "sick." In all control groups combined, there were just 34 checkups recorded, 1·2% of total visits in those group, and zero in the concurrent control at different facilities group. Conversely, 20·2% (n = 115) of visits in the intervention group were for checkups instead of in response to a health problem.

Most frequent diagnoses {#sec019}
-----------------------

The most common diagnoses across all groups were upper respiratory tract infections (URTI), malaria and injury. The intervention group had the lowest proportion of URTI diagnoses (20·6%, n = 136). On average, 26·2% (n = 1066) of visits resulted in a URTI diagnosis in all groups. For malaria, the proportion was lowest (20·6%, n = 136) in the intervention group. Injuries were diagnosed at 9·8% (n = 65) of MC visits ([Table 5](#pone.0224749.t005){ref-type="table"}). During checkups in the intervention group (n = 115), the top two diagnoses were URTI (15·7%, n = 18) and hypertension (12·2%, n = 16).

10.1371/journal.pone.0224749.t005

###### Frequency of diagnoses in all groups.
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  Diagnosis                          Intervention group   Concurrent control at different facilities group   Historic control group   Concurrent control at intervention facilities group                        
  ---------------------------------- -------------------- -------------------------------------------------- ------------------------ ----------------------------------------------------- ----- ------- ------ -------
  Allergy                            20                   3.0%                                               5                        0.7%                                                  12    1.5%    12     0.6%
  Arthritis                          14                   2.1%                                               9                        1.3%                                                  8     1.0%    14     0.7%
  Cellulitis                         0                    0.0%                                               9                        1.3%                                                  11    1.4%    39     2.1%
  Dental                             7                    1.1%                                               29                       4.1%                                                  6     0.7%    9      0.5%
  Diabetes                           11                   1.7%                                               0                        0.0%                                                  4     0.5%    13     0.7%
  Enteric Fever                      23                   3.5%                                               16                       2.2%                                                  5     0.6%    2      0.1%
  Epilepsy                           10                   1.5%                                               4                        0.6%                                                  9     1.1%    23     1.2%
  Fungal infection                   17                   2.6%                                               12                       1.7%                                                  17    2.1%    13     0.7%
  Gastroenteritis                    27                   4.1%                                               26                       3.6%                                                  22    2.7%    63     3.4%
  Hypertension                       25                   3.8%                                               12                       1.7%                                                  5     0.6%    26     1.4%
  Injury/Trauma                      65                   9.8%                                               67                       9.4%                                                  64    7.9%    189    10.1%
  Malaria                            136                  20.6%                                              155                      21.7%                                                 236   29.1%   514    27.4%
  Missing                            30                   4.5%                                               2                        0.3%                                                  18    2.2%    37     2.0%
  Myalgia                            0                    0.0%                                               16                       2.2%                                                  20    2.5%    78     4.2%
  Neuritis                           14                   2.1%                                               1                        0.1%                                                  4     0.5%    2      0.1%
  Other                              64                   9.7%                                               95                       13.3%                                                 81    10.0%   218    11.6%
  Pneumonia, Asthma, Pleurisy/LRTI   5                    0.8%                                               9                        1.3%                                                  29    3.6%    35     1.9%
  PUD                                25                   3.8%                                               19                       2.7%                                                  10    1.2%    21     1.1%
  Sexual Dysfunction                 2                    0.3%                                               0                        0.0%                                                        0.0%           0.0%
  STI                                14                   2.1%                                               23                       3.2%                                                  24    3.0%    43     2.3%
  URTI                               136                  20.6%                                              190                      26.6%                                                 224   27.6%   516    27.5%
  UTI                                46                   7.0%                                               18                       2.5%                                                  20    2.5%    45     2.4%
  Total                              661                                                                     715                                                                            811           1875    

Reproductive health services {#sec020}
----------------------------

We investigated how many men were diagnosed with STIs and/or sexual dysfunction at MCs compared to the control groups in pursuit of the "male-friendly" hypothesis that men were more likely to want to address these sensitive issues in an MC environment versus a regular clinic. We compared the number of STI diagnoses in control groups with the intervention group. STI diagnoses were the result of 2·6% of MC visits (n = 14), 3·6% of visits in the "concurrent control at different facilities" group, 3·3% in the historic control group, 2·6% in the "concurrent control at intervention facilities" group, and 2·97% (n = 90) of visits in all control groups combined. Differences in STI diagnoses across all groups were not statistically significant (p = 0·5043).

Sexual dysfunction was a recorded diagnosis at two visits in the intervention group and at zero visits in all control groups. The small number is not enough to draw a meaningful conclusion.

Within the intervention group, 25 syphilis screenings occurred, of which five were positive. After malaria, PITC for HIV was the second most common test at all intervention clinics except for Ramula, where it was the most common. PITC was offered 184 times and made up 27·4% of all tests (n = 672). There was no statistically significant difference in PITC offering by clinic (p = 0·11).

Quality of care {#sec021}
---------------

Rates of correct treatment for diagnosis by group varied significantly. The intervention group had the smallest proportion of correct treatments by diagnosis (82·9%, n = 165) compared to all control groups (p\<0·0001). This figure did not vary greatly among control groups, ranging from 93·3% in the historic control group to 90·9% in the "concurrent control at different clinics" group. Out of six common diagnoses, malaria and epilepsy were treated correctly 100% and 95% of the time respectively in the intervention group while fungal infections were treated correctly 25% of the time ([Table 6](#pone.0224749.t006){ref-type="table"}). The proportion of correct treatment for diagnosis in the intervention group ranged from 25·0% (n = 3) for fungal infections to 100% (n = 10) for epilepsy.

The proportion of times PITC was offered in the intervention group was high for patients who did not know their HIV status (90·3%, n = 149), compared to those who already knew their HIV status (8·5%, n = 34), p\<0·0001.

10.1371/journal.pone.0224749.t006

###### Proportion of correct treatments for select diagnoses at Male Clinics.
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                         Number of correct treatments   Percent correct   Number of incorrect treatments   Percent incorrect
  ---------------------- ------------------------------ ----------------- -------------------------------- -------------------
  Malaria                129                            94.9              6                                10.2
  Fungal infections      3                              25.0              9                                75.0
  Hypertension           7                              36.8              12                               63.2
  Diabetes               2                              50.0              2                                50.0
  Epilepsy               10                             100.0             0                                0.0
  Peptic ulcer disease   14                             73.7              5                                26.3
  Missing                31                                                                                

Discussion {#sec022}
==========

Women regularly access health services, either for their own health or for their children. In contrast, in most parts of the world, men do not access health services as frequently. This phenomenon is unrelated to a difference in need for services \[[@pone.0224749.ref012]\]. Most health programs in low-resource settings are designed for women and children, with few exceptions focusing on men as clients in their own right \[[@pone.0224749.ref021]--[@pone.0224749.ref022]\]. Based on findings from our early focus group discussions, cost of services, distance to the facility and associated cost of transport, as well as quality of services were reported as the main barriers to seeking care. We also found that men sometimes do not access health services because they associate care-seeking behavior with weakness, feel it is not worth missing a day's salary, or believe health centers to be places for women and children that are not catered to their direct needs. These findings are consistent with previous research \[[@pone.0224749.ref012], [@pone.0224749.ref023]--[@pone.0224749.ref025]\]. As a result, many men access health services primarily for curative care \[[@pone.0224749.ref026]--[@pone.0224749.ref027]\] and at an advanced stage of a health issue \[[@pone.0224749.ref016]--[@pone.0224749.ref017]\].

In response, we launched MCs to address men's concerns and to provide services tailored to their needs, with the goal of improving health-seeking behavior. While MCs could not directly respond to the issues reported during focus groups associated with distance to the facility or cost of transport, MCs did directly addressed the problems of service costs and wait times.

The number of total visits at MCs was significantly higher compared to regular clinics across all control groups. Additionally, among visits where the reason was known, more men in MCs accessed services for a check-up (20·2% of the time) compared to all control groups (1·2% of visits). The high rate of utilization of preventive care at MCs is important given the general trend of low uptake of health resources among men, particularly at early stages of a health issue. In MCs, the amount of check-ups might indicate that more men would likely access preventive health services in the context of MCs where all services are free---not just for pregnant women and children---and when the wait time is short.

The largest number of visits within the intervention group were to Sauri clinic. This could be explained by the fact that services at Sauri were already free in addition to the MCs. Also, unlike other facilities in the area, Sauri clinic is closest to the referral hospital, was recently constructed, and had a large staff with good management. Conversely, other clinics sometimes experienced commodities stock-outs and were smaller.

We also noted that half of MC visits were from men who had accessed services at MCs before. This is a desired positive outcome for health facilities that want to monitor progress of their patients in a context where most male patients fail to return for follow-ups, or want their patients to come in the early stages of any ailment. We could not compare this result to control groups because these data were not captured in general outpatient services.

Close to 10% of MC visits were from men who presented with an injury, which is about the same proportion as in all control groups. This is notable considering that MCs were only held once monthly, but the proportion was similar to control groups where patients could get services every day. This may indicate that these patients did not visit the regular clinic on the day of the injury, but waited for MC as a way of minimizing their costs and wait time for services.

Our analysis demonstrated that the quality of care, measured as the percentage of adequate treatment for six common diagnoses, was the lowest in MCs as compared to control groups, though correct prescribing was high across all groups. This could be due to myriad factors, including potential recording bias in the control facilities---only data from entries recording both diagnosis and treatment provided could be used for our analysis, which was a subset of all the entries in the registers that are often poorly filled out---potentially limited commodity availability in the MCs leading to unavailability of correct medicines and small sample size for certain conditions leading to disproportionately high rates of incorrect treatment (e.g. n = 19 total treatments for hypertension and n = 4 for diabetes).

During MC sessions, PITC was accepted at over 90% (n = 149) of visits where patients reported not knowing their HIV status. This is an added benefit of MCs, which could assist in reaching the first goal of the UNAIDS 90-90-90 targets \[[@pone.0224749.ref028]\]. In control registers, data on which visits resulted in PITC are available but whether the patient had existing knowledge of his status was not reported.

Additionally, rates of STI screening were not significantly higher at MCs compared to controls, despite the private setting available. The positivity rate following STI screening at MCs was the same as in control groups, which is expected since the male population is comparable across groups.

Finally, some practices following the inception of MCs contradicted results from the focus group discussions. For example, when asked for common reasons men would go to a clinic, 3·2% (n = 4) said for check-ups. Conversely, 20·2% of visits to MCs were for check-ups, indicating that perhaps there is greater demand for preventive services than had been anticipated.

Future research could consider investigating whether the gender of a provider impacts uptake and types of services. If men prefer male providers for services similar to those provided in MCs, uptake might be hindered by the dearth of male service providers at lower tiers of the health workforce \[[@pone.0224749.ref029]\]. Further research could also explore the impact of no-cost services on male health-seeking behavior.

Limitations {#sec023}
===========

The main limitation of this study is the difference in information captured using the MC registers compared with control registers. We developed the MC registers to collect all information needed to demonstrate impact, but similar information was not always available in existing national registers which was the source of information for the control populations. As a result, "services offered," such as blood pressure or STI screenings, tests given, or revisits were not systematically recorded in the control data. Additionally, registers are commonly lost in clinics, and are typically not kept very long once they are full, which made collection of historic data challenging. For example, records from the "concurrent control at different clinics" group were only available for part of the needed duration---from July 2015-November 2015 instead of November 2014-November 2015. Second, for confidentiality purposes, we did not collect personal identifiers. As a result, only distinct visits were tracked because it was not possible to track individual patients. This prevented us from distinguishing whether a revisit at MC was for continuing treatment of an existing illness or for a new ailment. Third, the algorithm to determine quality of care only took into consideration diagnoses with specific treatment options and assumed accurate diagnosis. This may not accurately reflect the quality of care for all services provided. Additionally, comparison of MC data with historical controls can be confounded by other temporal changes that may have impacted health seeking behavior, but this was mitigated through the concurrent control clinic comparisons.

Ethical considerations {#sec024}
======================

For focus group discussions, consent of adult men (age 18 and above) was written. No consent was needed from men subsequently attending MCs as all services provided are standard services available and approved by the Kenyan Ministry of Health. However, for patient privacy, patient names or other identifiable information were never recorded.

The protocol was approved by the Columbia University Institutional Review Board under protocol numbers IRB-AAAM0256 and AAAO2750. The study was also approved in Kenya by the Office of the President/Ministry of Interior and Coordination of National Government under reference number CORR 3\\R\\5\\att\\200.

Conclusion {#sec025}
==========

This research shows that an intervention focusing specifically on men as health-seeking agents in their own right, instead of targeting men as part of a health package geared toward their female partners and children, can successfully lead to increased male attendance and return visits. Creating an enabling environment for men at health centers as this study did can therefore improve uptake of preventive care. The Male Clinics intervention successfully engaged men in regular check-ups despite the socially-constructed barriers of gender norms which paint care-seeking as feminine.

Whereas a woman's health-seeking behavior might be triggered by a key life event such as childbirth, men do not have an equivalent event that would initiate a defined interaction with the health system. Standardizing the concept of Male Clinics in low-income countries could be an effective way to (re)connect men with health services. In the many contexts where there is a financial barrier to providing free care to all men, Ministries of Health, particularly in countries where men rarely seek care, may consider designing a specific life-defining moment where every man should visit a health center and the care given would also be free, as it is during MCs. This could be when men reach a specific age or at the birth of every one of his children. This would provide the benefits of MCs in that it would increase the uptake of preventive care, and thus significantly limit the funding required.

Supporting information {#sec026}
======================

###### Male Clinics consultation form.

This is the form that was filled out by Male Clinics staff at each patient visit.

(DOCX)

###### 

Click here for additional data file.

###### Interview guide.

This is the interview guide used for focus group discussions.

(PDF)

###### 

Click here for additional data file.

###### Focus group questionnaire.

This is the questionnaire used during focus group discussions.

(PDF)

###### 

Click here for additional data file.

###### Consent form.

This is the consent form used to recruit patients for the study.

(PDF)

###### 

Click here for additional data file.

###### Code book.

This is the code book describing all the codes from the dataset.

(DOCX)

###### 

Click here for additional data file.

###### Male Clinics data_aggregation.

This is the entire dataset for the Male Clinics study.

(XLSX)

###### 

Click here for additional data file.
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Reviewer \#1: This is an important study as most health services globally tend not to focus on men and worse so in low resource settings yet men need to be empowered and enabled to use services.

The design is sound and the literature reviewed shows the gaps that exit in in this discipline.

The statistical analysis that was conducted was appropriate and answered what the researcher set out to do.

Lines 231-236 and table 5 : Can the researchers clarify their definition of RTI. Pneumonia and pleurisy are these not RTIs.

Table 5: UTIs and STIs. Can the researchers clarify how these were differentiated and confirmed ( laboratory or syndromic).

Line 248: PITC was the second most common test done. In which facilities? Would be helpful to report comparison results from the intervention, comparison and historic data.

Quality of care section. Line 251

This is a very important section in this study. The researchers can enrich the paper by elaborating this section to show if there were statistical differences on this outcome for the intervention and comparison sites.

Service utilization:

Were the opening hours the same in the intervention and control sites? Can this be specified.

Conclusion section Line 356

Lines 364-367: The recommendations made in this section are not backed by findings from the study. Researchers need to modify this section to be more explicit in line with the study findings.

Reviewer \#2: The manuscript is well written and it fills an important gap in the literature. The multi-disease approach to men's health is an important area to further explore as health services in some African countries tend to be siloed due to donor priorities. The paper highlights the benefit of a general health approach (rather than a disease-based approach) to engage men in health services.
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1\. Table 5 seems to lump HIV diagnosis with STIs. Is it possible to separate them? This would be helpful for those in the HIV field. Indeed, engaging men in HIV services has been deemed as a blind spot in the HIV response. It would be helpful if more details on HIV diagnosis are included in the paper.

2\. In the section of reproductive health, I am not sure if it makes sense to compare results from the treatment group to "all" control groups, especially since I am assuming this would include the historical control group (line 244-245). It may be better to compare to separate control groups.

3\. It is well established that men's health seeking behaviors are influenced by masculinity norms. This comes out tangentially in the paper in lines 271-273. The paper highlights cost of services, distance to the facility, cost of transport, and quality of services as the main barriers. While this may have been the main barriers cited by men, it is important not to discount the gender norms issues cited in line 271-273. I suggest finding a way to make sure those are not lost in the manuscript.

4\. Another important aspect in the manuscript is that the intervention was successful in engaging men in regular check ups (compared to controls). This also needs to be highlighted in the discussion and conclusion.

5\. For circumcision services, it may be helpful to indicate if the sites are high volume or low volume sites and provide the range of clients. Typically, in high volume sites hundreds of boys/men may access VMMC services. That clarification is important to understand the context

6\. The age range of the men participants is important. Also, if you can provide any short table with socio-demographic characteristics that would be a bonus to help the reader understand who are the men who accessed MC.
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September 30, 2019

To the Reviewers and Editors,

Thank you for your careful review of our submission titled, "The impact of 'male clinics' on health-seeking behaviors of adult men in rural Kenya." Please find our point-by-point responses below.

JOURNAL REQUIREMENTS

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

Our manuscript meets PLOS ONE's style requirements, including those for file naming.

2\. Please provide additional details regarding participant consent of the focus group/interview part of your study. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information

For the focus groups discussions, consent of adult men (age 18 and above) was written. This was added in the Ethical Considerations section (line 366).

3\. Please include a copy of the interview guide used in the study, in both the original language and English, as Supporting Information, or include a citation if it has been published previously.

A copy of the interview guide (S2 Appendix Interview Guide), questionnaires of the focus groups (S3 Appendix Focus Group Questionnaire) and Consent form (S4 Appendix Consent Form) have been included as supplementary documents.

4\. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see <http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions>.

In your revised cover letter, please address the following prompts:

a\) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b\) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see <http://www.bmj.com/content/340/bmj.c181.long> for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see <http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories>.

We will update your Data Availability statement on your behalf to reflect the information you provide.

We have uploaded the minimal anonymized data set (S5 Appendix Male Clinics data and S6 Appendix Code Book)

Consent for publication of raw data was not obtained but dataset is fully anonymous in a manner that can easily be verified by any user of the dataset. Publication of the dataset clearly and obviously presents minimal risk to confidentiality of study participants. It was not possible to obtain consent from participants because the quantitative data was not collected from individuals but from clinic registers and the unit of analysis is a clinic visit not a patient.

REVIEWER 1:

Lines 231-236 and table 5: Can the researchers clarify their definition of RTI. Pneumonia and pleurisy are these not RTIs.

We thank the reviewer for spotting this. Pneumonia and asthma are Lower Respiratory Tract Infections (LRTI). To prevent confusion, we removed in tables 1 and 5 the mention of RTI and specified URTI and LRTI, where appropriate.

Table 5: UTIs and STIs. Can the researchers clarify how these were differentiated and confirmed (laboratory or syndromic).

The diagnosis of UTIs and STIs was syndromic, except specifically for syphilis where the Venereal Disease Research Laboratory (VDRL) test was used.

Line 248: PITC was the second most common test done. In which facilities? Would be helpful to report comparison results from the intervention, comparison and historic data.

PITC was the second most common test offered in intervention clinics across the board except for Ramula where it was the most common. Tests offered were only recorded in the intervention group so we cannot compare across groups. We thus did the assessment in the intervention group only and found that there was no statistically significant difference in PITC offering by intervention clinic (p= 0.1152). A clarification on this point has been added to the "Reproductive health services" section (lines 259-262).

Quality of care section. Line 251

This is a very important section in this study. The researchers can enrich the paper by elaborating this section to show if there were statistical differences on this outcome for the intervention and comparison sites.

We did not disaggregate the quality of care outcome by control group because there was such a small difference amongst them. Instead we conducted the analysis by combining all control groups. More detail has been added to this effect in the "Quality of care" section, lines 267-269. For the reviewers' reference, the proportion of correct treatments by diagnosis was 90.91% in the "concurrent control at different clinics" group, 93.3% in the historic control group, and 90.94% in the "concurrent control at intervention clinics" group.

Service utilization:

Were the opening hours the same in the intervention and control sites? Can this be specified.

Yes, the hours were the same. This has been added to the "Evaluation design" portion on line 150.

Conclusion section Line 356

Lines 364-367: The recommendations made in this section are not backed by findings from the study. Researchers need to modify this section to be more explicit in line with the study findings.

We thank the reviewer for this suggestion. We have rewritten this section to make it more in line with our findings about engaging men in preventive care. This is reflected in lines 382-391.

REVIEWER 2:

The manuscript is well written and it fills an important gap in the literature. The multi-disease approach to men's health is an important area to further explore as health services in some African countries tend to be siloed due to donor priorities. The paper highlights the benefit of a general health approach (rather than a disease-based approach) to engage men in health services.

Thank you for your review and this comment. The reviewer's last sentence here has been added to the introduction, lines 86-87.

Specific comments/suggestions

1\. Table 5 seems to lump HIV diagnosis with STIs. Is it possible to separate them? This would be helpful for those in the HIV field. Indeed, engaging men in HIV services has been deemed as a blind spot in the HIV response. It would be helpful if more details on HIV diagnosis are included in the paper.

Thank you for this suggestion. Table 5 shows positive diagnoses for each condition, as opposed to the number of patients tested for the condition. For example, there were 11 patients diagnosed with diabetes in the intervention group. The number of patients tested for diabetes would be much higher. We did not record a patient's positive or negative HIV status, rather we tracked whether a patient was aware of his HIV status. As a result, in Table 5, STI does not include HIV. Therefore, we are unable to disaggregate STI from HIV in the results or to report more thoroughly on HIV diagnoses of MC participants. However, we did record whether PITC was administered when a patient was unaware of his status, and that result is reported lines 279-281.

2\. In the section of reproductive health, I am not sure if it makes sense to compare results from the treatment group to "all" control groups, especially since I am assuming this would include the historical control group (line 244-245). It may be better to compare to separate control groups.

We have done an assessment of STI diagnosis by individual groups (as opposed to combined control groups). We found no statistically significant difference in STI diagnosis by intervention or control group (p = 0.5043). The proportion of visits resulting in an STI diagnosis by group was added to the \"Reproductive health services\" section, lines 252-255.

3\. It is well established that men's health seeking behaviors are influenced by masculinity norms. This comes out tangentially in the paper in lines 271-273. The paper highlights cost of services, distance to the facility, cost of transport, and quality of services as the main barriers. While this may have been the main barriers cited by men, it is important not to discount the gender norms issues cited in line 271-273. I suggest finding a way to make sure those are not lost in the manuscript.

We thank you for this suggestion. Further mention of this has been added to the conclusion, lines 379-381.

4\. Another important aspect in the manuscript is that the intervention was successful in engaging men in regular check ups (compared to controls). This also needs to be highlighted in the discussion and conclusion.

This has been highlighted in the discussion, lines 298-302 and conclusion, lines 379-381.

5\. For circumcision services, it may be helpful to indicate if the sites are high volume or low volume sites and provide the range of clients. Typically, in high volume sites hundreds of boys/men may access VMMC services. That clarification is important to understand the context

Information about how VMMC played a role in the context of male clinics has been added to the Study area section, lines 102-104.

6\. The age range of the men participants is important. Also, if you can provide any short table with socio-demographic characteristics that would be a bonus to help the reader understand who are the men who accessed MC.

Because age was the only demographic variable measured, we did not add a table. We added a more detailed description of men who accessed MC in the "demographics" section, lines 217-219.
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